REGENCY CENTERS CORP·4

May 12, 10:18 AM ET

BLANKENSHIP C RONALD 4

Research Summary

AI-generated summary

Updated

Regency Centers Director C. Ronald Blankenship Receives 1,952 Shares

What Happened
C. Ronald Blankenship, a director of Regency Centers Corp (REG), received a total of 1,952 shares on May 11, 2026 through conversion/vesting of derivative awards (1,875 shares and 77 shares). The filing shows the derivative conversion recorded with no cash paid (disposition entries at $0.00; acquisition entries list price as N/A). These shares arose from vesting of restricted stock and settlement of dividend equivalent rights.

Key Details

  • Transaction date: May 11, 2026; Form 4 filed May 12, 2026 (timely).
  • Transaction code: M (exercise/conversion of derivative security).
  • Shares involved: 1,875 + 77 = 1,952 shares.
  • Reported price: acquisition lines show N/A; derivative conversion/disposition lines show $0.00 (no cash exchanged).
  • Shares owned after transaction: not specified in the provided filing.
  • Footnotes: F1 = vesting of restricted stock under Regency’s Omnibus Incentive Plan; F2 = settlement of dividend equivalent rights (each equivalent converted into one share).
  • No open-market sale or purchase reported; shares resulted from award/vesting.

Context
This was a vesting/conversion of equity awards (restricted stock and accrued dividend equivalents) rather than a market buy or sale. Such vesting is routine compensation for insiders and does not by itself indicate a director’s buying or selling sentiment.